INSIGHTS ON CLINICAL TRIAL DESIGN
-
Want A Smooth RTSM Build? Start With These Three Tips
Effective RTSM planning requires listening to PM guidance, escalating unclear protocol points efficiently, and designing systems that allow for real clinical judgment.
-
The Triple Effect Of Community-Based Clinical Trials
Taking trials into local communities improves access, boosts enrollment, reduces dropouts, and yields more representative data, speeding timelines and strengthening study quality.
-
Tracking Functional Capacity To Advance Neuromuscular Disease Research
This presentation introduces a dual-endpoint approach to monitoring neuromuscular disease progression through two high-centile digital measures.
-
Evolution Of ERP In Biotech And Integration Challenges
Consolidating various software systems enables efficient management of direct fees, pass-throughs, and investigator grants within a single platform, providing a complete view of your trials' financial health.
-
CNS Trials Are Difficult — Do They Have To Be?3/9/2026
Clinical trials for central nervous system therapies face significant obstacles to approval, including subjective endpoints and complex patient selection. Consider a strategic approach for success.
-
Five Preventable Clinical Design Pitfalls And How To Avoid Them7/21/2026
While late-stage trial attrition is often attributed to inadequate safety or efficacy, the true failure may be insufficient upstream planning and/or misalignment between clinical and commercial goals.
-
Breaking Silos In Drug Development: The Power Of An Integrated Model5/11/2026
Experts share how Altasciences' integrated Preclinical/Clinical model results in fewer handoffs, greater continuity, and accelerated progress from the nonclinical phase to first-in-human trials.
-
Oncology Clinical Trials Key Considerations: Planning For Success10/18/2024
Chief Scientific Officer Gabriel Kremmidiotis and CEO Yvonne Lungershausen from Avance Clinical delve into key strategies for conducting successful early-phase oncology trials for biotechs.
-
How AI Is Reshaping Clinical Development And Trial Execution8/6/2026
See how AI, real-world data, and agentic technologies are helping clinical teams improve patient selection, streamline operations, and speed trial outcomes.
CLINICAL TRIAL DESIGN SOLUTIONS
-
With over 40 clinical trials conducted in the area of ophthalmology, Altasciences combines depth of knowledge and expert capabilities to offer you a full range of early ophthalmic clinical development.
-
Get an overview of this groundbreaking synthetic data product – uniquely derived from Medidata’s exclusive repository of global, standardized historical clinical trial data.
-
Disconnected vendors mean disconnected data. Discover how a unified supply chain approach helps trial teams reduce risk, save time, and keep drug supply aligned with patient need.
-
Modernize research pharmacy operations with digital workflows that reduce manual effort, improve compliance, strengthen audit readiness, and help sites support more protocols with confidence.
-
Precision starts at collection. The integrity of trial data depends on accurate, compliant, and traceable sample handling, but standard kitting isn’t built for the demands of biomarker-driven research.